Hypomyelinating Leukodystrophy due to HSPD1 Mutations: A New Patient

Abstract

The hypomyelinating leukodystrophies (HMLs) encompass the X-linked Pelizaeus–Merzbacher disease (PMD) caused by PLP1 mutations and known as the classical form of HML as well as Pelizaeus–Merzbacher-like disease (PMLD) (Online Mendelian Inheritance in Man [OMIM] 608804 and OMIM 260600) due to GJC2 mutations. In addition, mutations in at least 10 other genes are known to cause HMLs. In 2008, an Israeli family with clinical and neuroimaging findings similar to those found in PMD was reported. The patients were found to have a homozygous missense mutation in HSPD1, encoding the mitochondrial heat-shock protein 60 (Hsp60), and the disorder was defined as the autosomal recessive mitochondrial Hsp60 chaperonopathy (MitCHAP-60) disease. We here report the first case of this severe neurodegenerative disease since it was first described. Given the fact that the families carried the same mutation our patient probably belongs to the same extended family as the Israeli family. In conclusion, the MitCHAP-60 disease should be considered as a rare differential diagnosis in HML.

Keywords

Pelizaeus–Merzbacher disease - brain hypomyelination - exome sequencing - mitochondrial Hsp60 chaperonopathy

• References

• 1 Magen D, Georgopoulos C, Bross P , et al. Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am J Hum Genet 2008; 83 (1) 30-42
• 2 van der Knaap MS, Breiter SN, Naidu S, Hart AA, Valk J. Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology 1999; 213 (1) 121-133
• 3 Garbern JY. Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis. Cell Mol Life Sci 2007; 64 (1) 50-65
• 4 Hobson GM, Garbern JY. Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders. Semin Neurol 2012; 32 (1) 62-67
• 5 Henneke M, Combes P, Diekmann S , et al. GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease. Neurology 2008; 70 (10) 748-754
• 6 Bugiani M, Al Shahwan S, Lamantea E , et al. GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy. Neurology 2006; 67 (2) 273-279
• 7 Wolf NI, Cundall M, Rutland P , et al. Frameshift mutation in GJA12 leading to nystagmus, spastic ataxia and CNS dys-/demyelination. Neurogenetics 2007; 8 (1) 39-44
• 8 Orthmann-Murphy JL, Enriquez AD, Abrams CK, Scherer SS. Loss-of-function GJA12/Connexin47 mutations cause Pelizaeus-Merzbacher-like disease. Mol Cell Neurosci 2007; 34 (4) 629-641
• 9 Uhlenberg B, Schuelke M, Rüschendorf F , et al. Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am J Hum Genet 2004; 75 (2) 251-260
• 10 Pouwels PJW, Vanderver A, Bernard G , et al. Hypomyelinating leukodystrophies: translational research progress and prospects. Ann Neurol 2014; 76 (1) 5-19
• 11 Hansen JJ, Dürr A, Cournu-Rebeix I , et al. Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am J Hum Genet 2002; 70 (5) 1328-1332
• 12 Hansen JJ, Bross P, Westergaard M , et al. Genomic structure of the human mitochondrial chaperonin genes: HSP60 and HSP10 are localised head to head on chromosome 2 separated by a bidirectional promoter. Hum Genet 2003; 112 (1) 71-77
• 13 Corydon MJ, Andresen BS, Bross P , et al. Structural organization of the human short-chain acyl-CoA dehydrogenase gene. Mamm Genome 1997; 8 (12) 922-926
• 14 Plecko B, Stöckler-Ipsiroglu S, Gruber S , et al. Degree of hypomyelination and magnetic resonance spectroscopy findings in patients with Pelizaeus Merzbacher phenotype. Neuropediatrics 2003; 34 (3) 127-136
• 15 Biancheri R, Rosano C, Denegri L , et al. Expanded spectrum of Pelizaeus-Merzbacher-like disease: literature revision and description of a novel GJC2 mutation in an unusually severe form. Eur J Hum Genet 2013; 21 (1) 34-39